Other studies have demonstrated the positive efficacy of andrographolide, for example, andrographolide can down-regulate Mir-21-5p by targeting NF-κB, promote the expression of the PDCD4 target gene, and further inhibit the growth and metastasis of metastatic luminal breast cancer (Li, 2021). The gene discussed is PDCD4; the disease is breast cancer.